Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1500447
European Journal of Endocrinology, Vol 150, Issue 4, 447-455
Copyright © 2004 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akamizu, T
Right arrow Articles by Kangawa, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akamizu, T
Right arrow Articles by Kangawa, K

Clinical Studies

Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects

T Akamizu, K Takaya, T Irako, H Hosoda, S Teramukai, A Matsuyama, H Tada, K Miura, A Shimizu, M Fukushima, M Yokode, K Tanaka, and K Kangawa

Ghrelin Research Project, Department of Experimnetal Therapeutics, Kyoto University Hospital, Kyoto University School of Medicine, Kyoto 606-8507, Japan.

OBJECTIVE: It has been demonstrated that ghrelin plays a major role in the regulation of GH secretion and food intake. These actions make ghrelin a strong candidate for the treatment of GH deficiency, anorexia and cachexia. However, only preliminary studies have been performed to assess ghrelin administration in humans. In this study, we have conducted a double-blind, randomized, placebo-controlled trial to investigate the pharmacokinetics, safety, and endocrine and appetite effects of ghrelin in young healthy volunteers. DESIGN: Eighteen male volunteers were randomly assigned into three groups of six subjects: low- and high-dose ghrelin groups, who received intravenous injections of 1 and 5 microg/kg ghrelin (acylated form) respectively, and a placebo group who were injected with mannitol instead of ghrelin. RESULTS: Acylated ghrelin disappeared more rapidly from plasma than total ghrelin, with elimination half life (t(1/2)) of 9-13 and 27-31 min respectively. The number of subjects that experienced adverse effects did not significantly differ among the three groups, and all adverse effects were transient and well tolerated. Both the low and high doses of ghrelin strongly stimulated GH release (peak plasma concentration (C(max,0-90 min)): 124.2+/-63.9 and 153.2+/-52.2 ng/ml for 1 and 5 microg/kg ghrelin respectively). Slight alterations of blood glucose and insulin levels after the injection were observed. Although not statistically significant, ghrelin administration tended to increase hunger sensation in a dose-dependent manner. CONCLUSIONS: These results suggest that ghrelin is safe, and that clinical trials may be started to assess the usefulness of ghrelin for the treatment of disorders related to GH secretion and appetite.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. Paulo, R. Brundage, M. Cosma, K. L. Mielke, C. Y. Bowers, and J. D. Veldhuis
Estrogen Elevates the Peak Overnight Production Rate of Acylated Ghrelin
J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4440 - 4447.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, G. A. Reynolds, A. Iranmanesh, and C. Y. Bowers
Twenty-Four Hour Continuous Ghrelin Infusion Augments Physiologically Pulsatile, Nycthemeral, and Entropic (Feedback-Regulated) Modes of Growth Hormone Secretion
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3597 - 3603.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
T. Akamizu, H. Iwakura, H. Ariyasu, H. Hosoda, T. Murayama, M. Yokode, S. Teramukai, H. Seno, T. Chiba, S. Noma, et al.
Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite.
Eur. J. Endocrinol., April 1, 2008; 158(4): 491 - 498.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Iranmanesh, P. C. Carpenter, K. Mielke, C. Y. Bowers, and J. D. Veldhuis
Putative Somatostatin Suppression Potentiates Adrenocorticotropin Secretion Driven by Ghrelin and Human Corticotropin-Releasing Hormone
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3653 - 3659.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. D. DeBoer, X. X. Zhu, P. Levasseur, M. M. Meguid, S. Suzuki, A. Inui, J. E. Taylor, H. A. Halem, J. Z. Dong, R. Datta, et al.
Ghrelin Treatment Causes Increased Food Intake and Retention of Lean Body Mass in a Rat Model of Cancer Cachexia
Endocrinology, June 1, 2007; 148(6): 3004 - 3012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. T. Vestergaard, T. K. Hansen, L. C. Gormsen, P. Jakobsen, N. Moller, J. S. Christiansen, and J. O. L. Jorgensen
Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1829 - E1836.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. R. Kraemer and V. D. Castracane
Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin
Experimental Biology and Medicine, February 1, 2007; 232(2): 184 - 194.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, D. M. Keenan, A. Iranmanesh, K. Mielke, J. M. Miles, and C. Y. Bowers
Estradiol Potentiates Ghrelin-Stimulated Pulsatile Growth Hormone Secretion in Postmenopausal Women
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3559 - 3565.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Veldhuis, A. Iranmanesh, K. Mielke, J. M. Miles, P. C. Carpenter, and C. Y. Bowers
Ghrelin Potentiates Growth Hormone Secretion Driven by Putative Somatostatin Withdrawal and Resists Inhibition by Human Corticotropin-Releasing Hormone
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2441 - 2446.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Toshinai, H. Yamaguchi, Y. Sun, R. G. Smith, A. Yamanaka, T. Sakurai, Y. Date, M. S. Mondal, T. Shimbara, T. Kawagoe, et al.
Des-Acyl Ghrelin Induces Food Intake by a Mechanism Independent of the Growth Hormone Secretagogue Receptor
Endocrinology, May 1, 2006; 147(5): 2306 - 2314.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T Akamizu, T Murayama, S Teramukai, K Miura, I Bando, T Irako, H Iwakura, H Ariyasu, H Hosoda, H Tada, et al.
Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure
J. Endocrinol., February 1, 2006; 188(2): 333 - 344.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
M. E. Gordon and K. H. McKeever
Diurnal variation of ghrelin, leptin, and adiponectin in Standardbred mares
J Anim Sci, October 1, 2005; 83(10): 2365 - 2371.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Zizzari, H. Halem, J. Taylor, J. Z. Dong, R. Datta, M. D. Culler, J. Epelbaum, and M. T. Bluet-Pajot
Endogenous Ghrelin Regulates Episodic Growth Hormone (GH) Secretion by Amplifying GH Pulse Amplitude: Evidence from Antagonism of the GH Secretagogue-R1a Receptor
Endocrinology, September 1, 2005; 146(9): 3836 - 3842.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Misra, K. K. Miller, K. Kuo, K. Griffin, V. Stewart, E. Hunter, D. B. Herzog, and A. Klibanski
Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents
Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E347 - E356.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. G. Smith, L. Betancourt, and Y. Sun
Molecular Endocrinology and Physiology of the Aging Central Nervous System
Endocr. Rev., April 1, 2005; 26(2): 203 - 250.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 European Society of Endocrinology.